Return On Assets of Marker Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Marker Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Marker Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -76%, a 5% decline year-over-year.
  • Marker Therapeutics, Inc. annual Return On Assets for 2024 was -73%, a 92% decline from 2023.
  • Marker Therapeutics, Inc. annual Return On Assets for 2023 was -38%, a 42% increase from 2022.
  • Marker Therapeutics, Inc. annual Return On Assets for 2022 was -65%, a 21% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Marker Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -76% -3.6% -5% 01 Jul 2025 30 Sep 2025
Q2 2025 -90% -24% -36% 01 Apr 2025 30 Jun 2025
Q1 2025 -83% -52% -166% 01 Jan 2025 31 Mar 2025
Q4 2024 -73% -35% -92% 01 Oct 2024 31 Dec 2024
Q3 2024 -72% -36% -101% 01 Jul 2024 30 Sep 2024
Q2 2024 -66% -24% -58% 01 Apr 2024 30 Jun 2024
Q1 2024 -31% +33% +51% 01 Jan 2024 31 Mar 2024
Q4 2023 -38% +27% +42% 01 Oct 2023 31 Dec 2023
Q3 2023 -36% +30% +46% 01 Jul 2023 30 Sep 2023
Q2 2023 -42% +25% +37% 01 Apr 2023 30 Jun 2023
Q1 2023 -64% -1.7% -2.7% 01 Jan 2023 31 Mar 2023
Q4 2022 -65% -11% -21% 01 Oct 2022 31 Dec 2022
Q3 2022 -66% -9.5% -17% 01 Jul 2022 30 Sep 2022
Q2 2022 -67% -13% -24% 01 Apr 2022 30 Jun 2022
Q1 2022 -62% -8.8% -16% 01 Jan 2022 31 Mar 2022
Q4 2021 -54% +7.6% +12% 01 Oct 2021 31 Dec 2021
Q3 2021 -57% -2.5% -4.6% 01 Jul 2021 30 Sep 2021
Q2 2021 -54% -4.7% -9.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -54% -7.5% -16% 01 Jan 2021 31 Mar 2021
Q4 2020 -62% -21% -53% 01 Oct 2020 31 Dec 2020
Q3 2020 -54% +213% +80% 01 Jul 2020 30 Sep 2020
Q2 2020 -49% +285% +85% 01 Apr 2020 30 Jun 2020
Q1 2020 -46% +404% +90% 01 Jan 2020 31 Mar 2020
Q4 2019 -40% +725% +95% 01 Oct 2019 31 Dec 2019
Q3 2019 -267% +29% +9.7% 01 Jul 2019 30 Sep 2019
Q2 2019 -334% -87% -35% 01 Apr 2019 30 Jun 2019
Q1 2019 -450% -269% -148% 01 Jan 2019 31 Mar 2019
Q4 2018 -765% -614% -407% 01 Oct 2018 31 Dec 2018
Q3 2018 -296% -172% -139% 01 Jul 2018 30 Sep 2018
Q2 2018 -248% -153% -162% 01 Apr 2018 30 Jun 2018
Q1 2018 -181% 01 Jan 2018 31 Mar 2018
Q4 2017 -151% 01 Oct 2017 31 Dec 2017
Q3 2017 -124% 01 Jul 2017 30 Sep 2017
Q2 2017 -94% 01 Apr 2017 30 Jun 2017
Q2 2012 -2482% 01 Apr 2012 30 Jun 2012
Q1 2012 -919% 01 Jan 2012 31 Mar 2012

Marker Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -73% -35% -92% 01 Jan 2024 31 Dec 2024
2023 -38% +27% +42% 01 Jan 2023 31 Dec 2023
2022 -65% -11% -21% 01 Jan 2022 31 Dec 2022
2021 -54% +7.6% +12% 01 Jan 2021 31 Dec 2021
2020 -62% -21% -53% 01 Jan 2020 31 Dec 2020
2019 -40% +725% +95% 01 Jan 2019 31 Dec 2019
2018 -765% -614% -407% 01 Jan 2018 31 Dec 2018
2017 -151% 01 Jan 2017 31 Dec 2017
2012 -7631% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.